958 views | 7 years ago
Dr Eliezer Van Allen, Assistant Professor at Harvard Medical School and Medical Oncologist at the Dana Farber Cancer Institute, discusses his groundbreaking work in the genomics of cancer immunotherapy....
1377 views | 7 years ago
Alzheimer’s Disease is characterized by the presence of plaques and tangles inside an individual’s brain. Despite this clear pathological definition, the predisposing factors and effects of these plaques...
634 views | 7 years ago
In this webinar, Professor Florian Haller from the University Hospital Erlangen shares data from reliable and sensitive RNA fusion detection assays. His data compare TruSight[Symbol] RNA Pan Cancer...
751 views | 7 years ago
In this webinar, Tina Ziainia, MD, FACOG, an Obstetrician-Gynecologist affiliated with Sharp Health Care, provides insight and expertise on successfully implementing noninvasive prenatal testing (NIPT)...
3688 views | 7 years ago
Illumina would like to introduce our new addition — a 7-acre, 316,000 square-foot complex called the i3 campus. Consisting of three buildings, the i3 campus emphasizes openness, with ample windows to...
317 views | 7 years ago
Dr Eliezer Van Allen, Assistant Professor at Harvard Medical School and Medical Oncologist at the Dana Farber Cancer Institute, discusses his groundbreaking work in the genomics of cancer immunotherapy....
627 views | 7 years ago
Helene Peyro-Saint-Paul, MD, Chief Medical Officer of PathoQuest provides an overview of the development, validation and clinical evaluation of the iDTECT™ Blood Test. This test uses a next-genome sequencing...
343 views | 7 years ago
Illumina Accelerator graduate, Resilient Biotics, Inc., shares its experiences on launching a breakthrough genomics startup. Hear from Chris Belnap, PhD, CEO of Resilient Biotics about his journeys...